Table 3

Paired sample t-test analyses showing the change in points of NEI-VFQ-25 sub-scores from baseline to 12 months of antivascular endothelial growth factor treatment

NEI-VFQ-25 subscoresChange in points from baseline to 12 months (CI)P value
General health−4.0 (−7.6 to −0.4)0.029
General vision6.1 (3.2 to 9.0)0.000
Ocular pain0.7 (−3.0 to 4.4)0.692
Near vision3.3 (0.3 to 6.3)0.033
Distance vision0.8 (−2.6 to 4.2)0.642
Social function0.9 (−1.9 to 3.7)0.535
Mental health5.8 (3.6 to 8.0)0.000
Role difficulties3.9 (−0.2 to 8.1)0.061
Dependency−1.2 (−3.7 to 1.2)0.322
Driving0.4 (−5.2 to 5.9)0.898
Colour vision−3.6 (−6.1 to −1.0)0.007
Peripheral vision−0.6 (−3.1 to 1.9)0.643
  • Bold denotes significant values: **p<0.001 and *p<0.05.

  • NEI-VFQ 25, National Eye Institute Visual-Functioning-Questionnaire-25.